Trial Profile
A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) [ixabepilone] Every 21 Days in Patients With Advanced Pancreas Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 17 Sep 2005 New trial record.